Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Quelques réflexions sur le double insu. Local targets link to admitted publications; unresolved targets remain external evidence.
Placebo et effet placebo
10.1016/s0003-4509(05)82309-0 · 2005 · External reference
Unresolved reference
External reference
The double blind in danger: untoward consequences of informed consent
10.1176/ajp.139.11.1487 · 1982 · External reference
Assessment of double blindness at the conclusion of the beta-blocker heart attack trial
10.1001/jama.1985.03350360059018 · 1985 · External reference
Inert placebo versus active medication. Patient blindability in clinical pharmacological trials
10.1097/00005053-199409000-00001 · 1994 · External reference
How study design affetcs outcomes in comparisons therapy
10.1002/sim.4780080408 · 1989 · External reference
In randomized controlled trials, should subjects in both placebo and drug groups be expected to guess that they are taking drug 50% of the time?
10.1016/s0306-9877(02)00205-0 · 2002 · External reference
Patient bias, investigator bias and the double masked procedure in clinical trials
10.1016/0002-9343(75)90594-x · 1975 · External reference
Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo, controlled trials
10.1136/bmj.37952.631667.ee · 2004 · External reference
How sound is the double blind design for evaluating psychotropic drugs?
10.1097/00005053-199306000-00002 · 1993 · External reference
Physiological performance following a hypnotic dose of a barbiturate
1951 · External reference
A meta-analysis of fluoxetine outcome in the treatment of depression
10.1097/00005053-199410000-00003 · 1994 · External reference
A method for the evaluation of the effects of drugs on cardiac pain in patients with angina of effort: a study of khelline
10.1016/0002-9343(50)90017-9 · 1950 · External reference
How blind was the patient blind in AIMS?
10.1038/clpt.1982.201 · 1982 · External reference
Blindness and the validity of the double blind procedure
10.1097/00004714-198506000-00003 · 1985 · External reference
Completeness of safety reporting in randomized trials. An evaluation of seven medical areas
10.1001/jama.285.4.437 · 2001 · External reference
Assessing the quality of reports of randomized clinical trials: is blinding necessary?
10.1016/0197-2456(95)00134-4 · 1996 · External reference
Intentional ignorance: a history of blind assessment and placebo controls in medicine
10.1353/bhm.1998.0159 · 1998 · External reference
Powerful placebo: the dark side of the randomised controlled trial
10.1016/s0140-6736(97)10111-8 · 1998 · External reference
Do medical devices have enhanced placebo effects?
10.1016/s0895-4356(00)00206-7 · 2000 · External reference
Ascorbic acid for the common cold: a prophylactic and therapeutic trial
10.1001/jama.1975.03240220018013 · 1975 · External reference
Are drug and placebo effects in depression additive?
10.1016/s0006-3223(00)00832-5 · 2000 · External reference
Unresolved reference
External reference
Paradoxical influence of a therapeutic side-effect interpretation
10.1001/archpsyc.1966.01730170014004 · 1966 · External reference
How “blind” are double blind studies?
10.1037/0022-006x.59.1.184 · 1991 · External reference
An evaluation of the double blind design in a study comparing lithium carbonate with placebo
10.1111/j.1600-0447.1976.tb00082.x · 1976 · External reference
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
10.1016/s0140-6736(98)01085-x · 1998 · External reference
Efficacy of antidepressants in adults
10.1136/bmj.331.7509.155 · 2005 · External reference
Meta-analysis of trials comparing antidepressants with active placebo
10.1192/bjp.172.3.227 · 1998 · External reference
In the dark: the reporting of blinding status in randomized controlled trials
10.1016/s0895-4356(02)00446-8 · 2002 · External reference
Actual medication versus therapist guesses: in a blind study, how blind is blind?
10.1097/00004714-198904000-00023 · 1989 · External reference
The double blind procedure: rationale and empirical evaluation
10.1097/00005053-196201000-00004 · 1962 · External reference
How blind is blind? Assessment of patient and doctor medication guesses in a placebo-controlled trial of imipramine and phenelzine
10.1016/0165-1781(86)90094-6 · 1986 · External reference
Is a double blind clinical trial really double blind?
10.1007/bf00404739 · 1970 · External reference
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
10.1001/jama.1995.03520290060030 · 1995 · External reference
Blinding in randomised trials: hiding who got what
10.1016/s0140-6736(02)07816-9 · 2002 · External reference
Side effects and placebo amplification
10.1192/bjp.140.1.64 · 1982 · External reference
Blinding effectiveness and association of pretreatment expectations with pain improvement in a double blind randomized controlled trial
10.1016/s0304-3959(02)00060-x · 2002 · External reference
The “double blind” method: its pitfalls and fallacies
10.1176/ajp.114.10.921 · 1958 · External reference
Side effects and the “blindability” of clinical drug trials
10.1176/ajp.149.12.1730 · 1992 · External reference
